BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma

British Journal of Cancer

Volumn 103, Issue 12, 2010, Pages 1808-1814

  Bodet, L ^a   Menoret E ^a   Descamps, G ^a   Pellat Deceunynck, C ^a   Bataille, R ^a   Le Gouill, S ^a,b   Moreau, P ^b   Amiot, M ^a   Gomez Bougie, P ^a,b  

^a Equipe 10 Labellisée Ligue Nationale Contre le Cancer 2008   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

apoptosis; Bcl 2; Bik; multiple myeloma; oxidative stress; TEF

Indexed keywords

BH3 PROTEIN; BIK PROTEIN; BIM PROTEIN; HYDROGEN PEROXIDE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; THYROTROPH EMBRYONIC FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN STABILITY; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; HUMANS; MEMBRANE PROTEINS; MULTIPLE MYELOMA; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650012656     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605981     Document Type: Article

References (24)

1. Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, Minvielle S, Bataille R (2002) Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 99: 2185-2191
2. Bataille R, Jégo G, Robillard N, Barillé-Nion S, Harousseau JL, Moreau P, Amiot M, Pellat-Deceunynck C (2006) The phenotype of normal, reactive and malignant plasma cells. Identification of 'many and multiple myelomas' and of new targets for myeloma therapy. Haematologica 91: 1234-1240
3. Blatt NB, Boitano AE, Lyssiotis CA, Opipari Jr AW, Glick GD (2009) Bz-423 superoxide signals B cell apoptosis via Mcl-1, Bak, and Bax. Biochem Pharmacol 78: 966-973
4. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, Chinnadurai G (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survivalpromoting proteins. Oncogene 11: 1921-1928
5. Castells A, Gusella JF, Ramesh V, Rustgi AK (2000) A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res 60: 2836-2839
6. Daniel PT, Pun KT, Ritschel S, Sturm I, Holler J, Dörken B, Brown R (1999) Expression of the death gene Bik/Nbk promotes sensitivity to druginduced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice. Blood 94: 1100-1107
7. Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A (2007) BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12: 171-185
8. Gillissen B, Essmann F, Graupner V, Stärck L, Radetzki S, Dörken B, Schulze-Osthoff K, Daniel PT (2003) Induction of cell death by the BH3- only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J 22: 3580-3590
9. Gillissen B, Essmann F, Hemmati PG, Richter A, Richter A, Oztop I, Chinnadurai G, Dörken B, Daniel PT (2007) Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis. J Cell Biol 179: 701-715
10. Han J, Sabbatini P, White E (1996) Induction of apoptosis by human Nbk/ Bik, a BH3-containing protein that interacts with E1B 19K. Mol Cell Biol 16: 5857-5864
11. Jorgensen TN, McKee A, Wang M, Kushnir E, White J, Refaeli Y, Kappler JW, Marrack P (2007) Bim and Bcl-2 mutually affect the expression of the other in T cells. J Immunol 179: 3417-3424
12. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183-192
13. Li YM, Wen Y, Zhou BP, Kuo HP, Ding Q, Hung MC (2003) Enhancement of Bik antitumor effect by Bik mutants. Cancer Res 63: 7630-7633
14. Magrangeas F, Lodé L, Wuilleme S, Minvielle S, Avet-Loiseau H (2005) Genetic heterogeneity in multiple myeloma. Leukemia 19: 191-194
15. Mathai JP, Germain M, Marcellus RC, Shore GC (2002) Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene 21: 2534-2544
16. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D (1999) Solution Structure of the Proapoptotic Molecule BID: A Structural Basis for Apoptotic Agonists and Antagonists. Cell 96: 625-634
17. Ocio EM, Mateos MV, Maiso P, Pandiella A, San-Miguel JF (2008) New drugs in multiple myeloma: Mechanisms of action and phase I/II clinical findings. Lancet Oncol 9: 1157-1165
18. Oppermann M, Geilen CC, Fecker LF, Gillissen B, Daniel PT, Eberle J (2005) Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik. Oncogene 24: 7369-7380
19. Puthalakath H, Strasser A (2002) Keeping killers on a tight leash: Transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9: 505-512
20. Ritchie A, Gutierrez O, Fernandez-Luna JL (2009) PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts. Cell Death Differ 16: 838-846
21. Sturm I, Stephan C, Gillissen B, Siebert R, Janz M, Radetzki S, Jung K, Loening S, Dörken B, Daniel PT (2006) Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ 14: 619-627
22. Toumi-Wuillème S, Trichet V, Gomez-Bougie P, Gratas C, Bataille R, Amiot M (2007) Reciprocal protection of Mcl-1 and Bim from ubiquitin-proteasome degradation. Biochem Biophys Res Commun 361: 865-869
23. Zhan F, Tian E, Bumm K, Smith R, Barlogie B, Shaughnessy Jr J (2003) Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101: 1128-1140
24. Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S., Epstein J, Yaccoby S, Sawyer J, Burington B, Anaissie E, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Walker R, Zangari M, Crowley J, Barlogie B, Shaughnessy Jr JD (2006) The molecular classification of multiple myeloma. Blood 108: 2020-2028